the annual 2015 financial results conference call is held on the basis of a review of the current status of the acelrx pharmaceuticals ( acx ) product candidates. the meeting is held on march 7, 2016. the meeting is held on the basis of a review of the current state of the research and development activities of the two products. the meeting will provide information on the process and timing of anticipated future development of the two products including the process and timing of anticipated future development of arx-04 andzalviso.